Question 1

What's the Syncom Formulations (India) Ltd share price today?

Accepted Answer

Syncom Formulations (India) Ltd share price was Rs 14.23 at 02:43 PM IST on 17th Jun 2026. Syncom Formulations (India) Ltd share price was down by 0.70% from the previous closing price of Rs 14.33. Syncom Formulations (India) Ltd share price trend:

Last 1 Month: Syncom Formulations (India) Ltd share price moved up by 4.18% on BSE
Last 3 Months: Syncom Formulations (India) Ltd share price moved up by 22.38% on BSE
Last 12 Months: Syncom Formulations (India) Ltd share price moved down by 29.81% on BSE
Last 3 Years: Syncom Formulations (India) Ltd price moved up by 78.64% on BSE

Question 2

How can I quickly analyse the performance of the Syncom Formulations (India) Ltd stock?

Accepted Answer

The performance of the Syncom Formulations (India) Ltd stock can be quickly analysed on the following metrics:

The stock's PE is 17.56
Price to book value ratio is 3.22
Dividend yield of 0.00
The EPS (trailing 12 months) of the Syncom Formulations (India) Ltd stock is Rs 0.81

Question 3

What is the market cap of Syncom Formulations (India) Ltd?

Accepted Answer

Syncom Formulations (India) Ltd has a market capitalisation of Rs 1,338 crore.

Question 4

What is Syncom Formulations (India) Ltd's 52-week high/low share price?

Accepted Answer

The Syncom Formulations (India) Ltd’s 52-week high share price is Rs 21.80 and 52-week low share price is Rs 10.21.

Question 5

Is the Syncom Formulations (India) Ltd profitable?

Accepted Answer

On a consolidated basis, Syncom Formulations (India) Ltd reported a profit of Rs 25.17 crore on a total income of Rs 149.97 crore for the quarter ended 2026. For the year ended Mar 2026, Syncom Formulations (India) Ltd had posted a profit of Rs 25.17 crore on a total income of Rs 149.97 crore.

Question 6

Which are Syncom Formulations (India) Ltd’s peers in the Health care sector?

Accepted Answer

Syncom Formulations (India) Ltd’s top 5 peers in the Health care sector are  Ind-Swift Labs., Jagsonpal Pharma, Shukra Pharma., Syncom Formul., Lincoln Pharma., Bajaj Healthcare, Themis Medicare.

Question 7

Who owns how much in Syncom Formulations (India) Ltd?

Accepted Answer

Key changes to the Syncom Formulations (India) Ltd shareholding are as follows:

Promoter holding in Syncom Formulations (India) Ltd has gone up to 50.57 per cent as of Mar 2026 from 50.57 per cent as of Jun 2025.
Indian Public holding in Syncom Formulations (India) Ltd has gone up to 45.16 per cent as of Mar 2026 from 44.83 per cent as of Jun 2025.
Non Institutional Investors holding in Syncom Formulations (India) Ltd has gone down to 4.05 per cent as of Mar 2026 from 4.19 per cent as of Jun 2025.
Foreign Institutional Investors holding in Syncom Formulations (India) Ltd has gone down to 0.21 per cent as of Mar 2026 from 0.41 per cent as of Jun 2025.
Other Institutional Investors holding in Syncom Formulations (India) Ltd has gone up to 0.01 per cent as of Mar 2026 from 0.00 per cent as of Jun 2025.
Financial Institutions holding in Syncom Formulations (India) Ltd has gone up to 0.00 per cent as of Mar 2026 from 0.00 per cent as of Jun 2025.
Insurance Companies holding in Syncom Formulations (India) Ltd has gone up to 0.00 per cent as of Mar 2026 from 0.00 per cent as of Jun 2025.
Mutual Funds Uti holding in Syncom Formulations (India) Ltd has gone up to 0.00 per cent as of Mar 2026 from 0.00 per cent as of Jun 2025.
Custodians holding in Syncom Formulations (India) Ltd has gone up to 0.00 per cent as of Mar 2026 from 0.00 per cent as of Jun 2025.

Market Cap (₹ Cr)	1,338
Traded Value (₹ Cr)	0.29
Volume (Shares)	2,04,016
Face Value (₹)	1

52-Week High (₹)	21.80
52-Week High Date	17-Jun-2025
52-Week Low (₹)	10.21
52-Week Low Date	30-Mar-2026

All Time High (₹)	27.94
All Time High Date	10-Sep-2024
All Time Low (₹)	0.14
All Time Low Date	15-Jan-1998

Syncom Formulations (India) Share Price

Syncom Formulations (India) Ltd